Related Experiment Video
Updated: Jan 17, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.5K
A Dose-Aware Model for Revealing Dose-Risk Relationship of Drug-Drug Interaction
Yi Shi1, Anna Sun1, Yuedi Yang1
1Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA.
CPT: Pharmacometrics & Systems Pharmacology
|September 18, 2025
Summary
A new dose-aware model (DAM) accurately estimates drug-drug interaction (DDI) dose-risk relationships (DRR). This approach improves upon existing methods, helping to reduce harm from adverse drug events.
Area of Science:
- Pharmacovigilance
- Biostatistics
- Computational Biology
Background:
- Drug-drug interactions (DDIs) are a significant cause of adverse drug events (ADEs).
- The precise dose-risk relationship (DRR) for two-drug combinations remains largely unknown.
- Traditional regression models may inaccurately estimate DRR due to misspecification.
Purpose of the Study:
- To develop a novel dose-aware model (DAM) for accurately estimating the dose-risk relationship (DRR) in DDIs.
- To improve the identification of optimal models for assessing the impact of two-drug exposure on ADE risks.
Main Methods:
- Development of a dose-aware model (DAM) to identify the optimal DRR from numerous potential models.
- Comparative analysis of DAM against standard models (exposed-versus-unexposed, dose-response, saturated) using real-world data.
- Validation of DAM performance through simulation studies for DRR estimation.
Main Results:
- DAM demonstrated superior performance metrics in model fitting with real-world data compared to conventional models.
- Simulation studies confirmed DAM's enhanced accuracy in estimating DRR.
- The model effectively identifies optimal dose-response relationships for drug combinations.
Conclusions:
- DAM is a powerful tool for estimating DRR in potential adverse two-drug combinations.
- This methodology can significantly contribute to mitigating harm caused by DDIs.
- The findings support the clinical utility of DAM in pharmacovigilance and drug safety.
Related Concept Videos
01:03Dose-Response Relationship: Overview
4.9K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.9K
01:15Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
01:22Dose-Response Relationship: Potency and Efficacy
6.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.4K
01:25Pharmacokinetics: Drug–Drug Interactions
364
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
364
01:21Dose Size and Dosing Frequency: Determination Methods
278
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
278
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256